葵花药业(002737) - 2022 Q1 - 季度财报

Financial Performance - Total revenue for Q1 2022 was ¥1,198,471,522.45, a decrease of 1.50% compared to ¥1,216,722,019.77 in the same period last year[4] - Net profit attributable to shareholders was ¥219,172,003.91, down 2.96% from ¥225,869,003.12 year-on-year[4] - Net profit excluding non-recurring gains and losses was ¥203,076,117.89, a decline of 5.60% from ¥215,120,160.37 in the previous year[4] - Net profit for the period was CNY 234,304,233.39, down from CNY 243,082,530.17 in the same period last year[26] - The net profit attributable to the parent company was 219,172,003.91, a decrease from 225,869,003.12, representing a decline of approximately 3.1%[29] - The total comprehensive income attributable to the parent company was 219,158,244.71, down from 225,888,266.00, reflecting a decrease of about 3.0%[29] - The basic and diluted earnings per share were both 0.38, compared to 0.39 in the previous period, indicating a decline of approximately 2.6%[29] Cash Flow - Net cash flow from operating activities increased by 94.87% to ¥430,597,673.80, compared to ¥220,961,896.05 in the same period last year[4] - Cash flow from operating activities generated a net amount of 430,597,673.80, an increase from 220,961,896.05, representing a growth of about 95.0%[33] - Cash inflow from investment activities was 355,539,307.25, up from 152,099,386.75, marking an increase of approximately 133.5%[36] - The net cash flow from investment activities was 25,527,371.83, a significant recovery from a negative cash flow of -81,082,611.47 in the previous period[36] - The net increase in cash and cash equivalents was 438,109,756.50, compared to a decrease of -33,670,023.55 in the prior period, indicating a turnaround[36] - The company's cash and cash equivalents at the end of the period amount to ¥1,763,281,813.20, an increase from ¥1,320,129,979.45 at the beginning of the year[15] - The total cash and cash equivalents at the end of the period reached 1,758,239,735.95, an increase from 1,614,236,608.43[36] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,745,185,918.48, reflecting a 1.95% increase from ¥5,635,203,544.61 at the end of the previous year[4] - The company's total assets increased to CNY 5,745,185,918.48 from CNY 5,635,203,544.61, marking a growth of 1.95%[22] - Total liabilities decreased to CNY 1,576,991,195.97 from CNY 1,700,079,714.65, a reduction of approximately 7.2%[22] - The total accounts receivable is ¥139,031,968.07, down from ¥194,746,659.98 at the beginning of the year[15] - Inventory at the end of the period is ¥550,568,874.73, a decrease from ¥709,638,552.08 at the beginning of the year[15] - The company reported a decrease in trading financial assets to ¥571,383,760.61 from ¥668,687,524.34[15] - Deferred income tax assets decreased to CNY 47,084,654.07 from CNY 55,780,116.02, a drop of about 15.6%[22] - The company maintained a stable short-term borrowing level at CNY 200,000,000.00, unchanged from the previous period[22] Shareholder Information - The total number of common shareholders at the end of the reporting period is 46,547[11] - The largest shareholder, KuaHua Group Co., Ltd., holds 45.41% of shares, totaling 265,200,000 shares[11] - The company has a pledged share amounting to 23,000,000 shares held by the largest shareholder[11] - The company has a shareholding plan involving employee stock ownership, with various shareholders holding small percentages[11] Investments and Expenses - Investment income rose by 51.41% to ¥369.36 million, attributed to increased investment in financial products[7] - The company reported a significant increase in cash flow from investment activities, up 131.48% to ¥2,552.74 million, primarily due to the redemption of financial products[7] - Total operating costs increased to CNY 924,211,409.04, up from CNY 906,568,193.56, reflecting a rise in sales expenses to CNY 321,201,460.89 from CNY 287,993,735.51[26] - Research and development expenses for the quarter were CNY 14,338,611.92, slightly up from CNY 13,792,037.35[26] Corporate Governance - The company has experienced changes in its board of directors, including the appointment of a new secretary[14] - The company has engaged in external investments, including fund subscriptions, as noted in multiple announcements[14] - The company has not undergone an audit for the first quarter report[37] Non-Recurring Items - Non-recurring gains and losses totaled ¥16,095,886.02 for the reporting period[6] - The company reported a decrease in other comprehensive income attributable to the parent company, with a net amount of -13,759.20 compared to 19,262.88 previously[29]